Abstract
Objectives: The wide application of transcatheter aortic valve implantation (TAVI) is currently limited from its complications rate, such as postoperative pacemaker implantation and paravalvular leaks. The aim of this analysis was to pool and compare the results of the new Sapien-3 and its predecessor Sapien-XT valve prosthesis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
